You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how BNGO scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
BNGO ($2.26) is undervalued by 3.78% relative to our estimate of its Fair Value price of $2.35 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
BNGO ($2.26) is not significantly undervalued (3.78%) relative to our estimate of its Fair Value price of $2.35 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
What is the 52 week high and low for Bionano Genomics (NASDAQ: BNGO)?
(NASDAQ: BNGO) Bionano Genomics's 52-week high was $6.28, and its 52-week low was $1.16. It is currently -64.01% from its 52-week high and 94.83% from its 52-week low.
How much is Bionano Genomics stock worth today?
(NASDAQ: BNGO) Bionano Genomics currently has 290,139,940 outstanding shares. With Bionano Genomics stock trading at $2.26 per share, the total value of Bionano Genomics stock (market capitalization) is $655.72M.
Bionano Genomics stock was originally listed at a price of $6.15 in Aug 21, 2018. If you had invested in Bionano Genomics stock at $6.15, your return over the last 3 years would have been -63.25%, for an annualized return of -28.37% (not including any dividends or dividend reinvestments).
How much is Bionano Genomics's stock price per share?
(NASDAQ: BNGO) Bionano Genomics stock price per share is $2.26 today (as of Aug 9, 2022).
What is Bionano Genomics's Market Cap?
(NASDAQ: BNGO) Bionano Genomics's market cap is $655.72M, as of Aug 10, 2022.
Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.
Bionano Genomics's market cap is calculated by multiplying BNGO's current stock price of $2.26 by BNGO's total outstanding shares of 290,139,940.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.